Mechanism of Photodynamic Occlusion Using Liposomal Zn(II)-Phtalocyanine

REFERENCES

• The Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with Verteporfin. Arch Ophthalmol 2001; 198–207
   PubMedGoogle Scholar
• Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult and no classic choroidal neovascularization. Am J Ophthalmol 2001; 131: 541–60, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Thomas E L, Tressler C S, Murphy R P. Efficacy of SnET2 photodynamic therapy for choroidal neovascularization in age-related macular degeneration: phase III pivotal trial results (ARVO Abstract). Invest Ophthalmol Vis Sci 2002; 43: 40, Abstract 983
   Google Scholar
• Blumenkranz M S, Woodburn K W, Quing F, et al. Lutetium texaphyrin (Lu-Tex): a potential new agent for ocular fundus angiography and photodynamic therapy. Am J Ophthalmol 2000; 129: 353–362, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schmidt-Erfurth U, Michels S, et al. Photodynamic effects on choroidal neovascularization and physiological choroid. Invest Ophthalmol Vis Sci. 2002; 43: 830–841, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Isele U, van Hoogevest P, Hilfiker R, et al. Large scale production of liposomes containing monomeric zinc phthalocyanine by controlle dilution of organic solvents. J Pharm Sci 1994; 83: 1608–1616, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Schieweck K, Ochsner M, Capraro H G, Isele U, et al. Investigator's brochure, CGP 55 847 Liposomal zinc (II)-phthalocyanine (Photosensitizer). Ciba-Geigy limited Pharma Division 1994; 1–34
   Google Scholar
• Schmidt-Erfurth U, Hasan T, Gragoudas E, et al. Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology 1994; 101: 1953–1961, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gomer C J, Rucker N, Murphree A L. Differential cell photosensitivity following porphyrin photodynamic therapy. Cancer Res. 1988; 48: 4539–4542, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Povlishock T J, Rosenblum W I, Sholley M M, Wei E P. An ultrastructural analysis of endothelial change paralleling platelet aggregation in a light/dye model of microvascular insult. Am J Pathol 1983; 110: 148–160, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Schmidt-Erfurth U, Hasan T, Schomacker K, et al. In-vivo uptake of liposomal benzporphyrin derivative and photothrombosis in experimental corneal neovascularization. Laser Surg Med. 1995; 17: 178–188
   PubMed Web of Science ®Google Scholar
• Kramer M, Miller J W, Michaud N, et al. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. Ophthalmology 1996; 103: 427–438, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Reinke M H, Canakis C, Husain D, et al. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Ophthalmology 1999; 106: 1915–1923, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zacks D N, Ezra E, Terada Y, et al. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization. Invest Ophthalmol Vis Sci 2002; 43: 2384–2391, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Peyman G A, Kazi A A, Unal M, et al. Problems with and pitfalls of photodynamic therapy. Ophthalmology 2000; 107: 29–35, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Schmidt-Erfurth U, Michels S. Long-term changes in confocal indocyanine green angiography following photodynamic therapy. Ophthalmology 2003; 110: 1306–1314, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Khoobehi B, Grinstead R, Passos E. Experimental photodynamic effects of hypocrellin A of the choriocapillaris. Ophthalmic Surg Lasers 2002; 33: 207–213, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Zhou C, Milanesi C, Jori G. An ultrastructural comparative evaluation of tumours photosensitized by porphyrins administered in aqueous solution, bound to liposomes or to lipoproteins. Photochem Photobiol 1988; 48: 487–492, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Jori G, Reddi E. Strategies for tumor targeting by photodynamic sensitizers. Photodynamic Therapy of Neoplastic Disease, D Kessel. CRC press, Boca Raton, FL 1990; 117–130
   Google Scholar
• Gal D, McDonald P C, Porter J C, et al. Cholesterol metabolism in cancer cells in monolayer culture. II. Low density lipoprotein metabolism. Int J Cancer 1981; 28: 315–319, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fracasso P M, Rodriguez L C, Herzog T J, et al. Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies. Cancer 2003; 98: 610–617, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schmidt-Erfurth U, Diddens H, Birngruber R, et al. Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates. Br J Cancer 1997; 75: 54–61, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Allison B A, Pritchard P H, Levy J. Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative. Br J Cancer. 1994; 69: 833–839, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Gijsens A, Derycke A, Missiaen L, et al. Targeting of the photocytotoxic compound AlPcS4 to Hela cells by transferrin conjugated PEG-liposomes. Int J Cancer 2002; 101: 78–85, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Voyta J C, Via D P, Butterfield C E, et al. Identification and isolation of endothelial cells based on their increased uptake of acetylated low-density lipoprotein. J Cell Biol. 1984; 99: 2034–2040, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Vlodavsky I, Fielding P E, Fielding C J, et al. Role of contact inhibition in the regulation of receptor-mediated uptake of low density lipoprotein in cultured vascular endothelial cells. Proc Natl Acad Sci USA 1978; 75: 356–360, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Takeuchi Y, Kurohane K, Ichikawa K, et al. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer. Cancer 2003; 15: 2027–2034, [CROSSREF]
   Google Scholar
• Miller J W, Schmidt-Erfurth U, Sickenberg M, et al. Photodynamic therapy of choroidal neovascularization due to age-related macular degeneration using verteporfin: Results of single treatments in a phase I an II study. Arch Ophthalmol. 199; 117: 1161–1177, [CSA]
   Google Scholar
• Michels S, Schmidt-Erfuerh U. Sequence of early vascular events after photodynamic therapy. Invest Ophthalmol Vis Sci 2003; 44: 2147–2154, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schlötzer-Schrehardt U, Viestenz A, Naumann G OH, et al. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefe's Arch Clin Exp Ophthalmol 2002; 240: 748–757, [CSA]
   PubMed Web of Science ®Google Scholar